ARX Equity Partners acquires Instrumentation Technologies, a global leader in advanced instrumentation for the particle accelerator and proton therapy markets

ARX Equity Partners (“ARX”) has agreed to complete the acquisition of Instrumentation Technologies (“I-Tech”, www.i-tech.si). Founded in 1998 and headquartered in Solkan, Slovenia, I-Tech is the global market leader in the development and assembly of high-specification instrumentation for data acquisition and signal processing used in scientific particle accelerators. Also core to the I-Tech strategy is utilizing the company’s know-how and R&D capabilities to develop instrumentation for medical proton therapy applications as well as broader industrial markets.

The transaction also includes Red Pitaya (www.redpitaya.com), a handheld electronics lab incorporating instruments such as oscilloscopes and signal generators and which is seeing widespread adoption among signal processing engineers, hobbyists and students.

ARX acquired the company from its founders and financial details of the transaction were not disclosed. Completion of the transaction is subject to customary closing conditions. As part of the transaction, ARX agreed to partner with the company´s existing management team who will lead the future growth and development of the Company.